A Phase I, 2-panel, Open-label, Randomized, Cross-over Trial in Healthy Subjects to Investigate the Pharmacokinetic Interaction Between TMC435 and Antiretroviral Agents, TMC278 and Tenofovir Disoproxil Fumarate (TDF), at Steady State.
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2012
At a glance
- Drugs Rilpivirine; Simeprevir; Tenofovir disoproxil fumarate
- Indications Hepatitis C; HIV infections
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 08 Mar 2012 Results presented at the 19th Conference on Retroviruses and Opportunistic Infections.
- 23 Nov 2011 Actual initiation date changed from Dec 2010 to Nov 2010 as reported by ClinicalTrials.gov.
- 23 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.